Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.
Doyon A, Fischer DC, Bayazit AK, Canpolat N, Duzova A, Sözeri B, Bacchetta J, Balat A, Büscher A, Candan C, Cakar N, Donmez O, Dusek J, Heckel M, Klaus G, Mir S, Özcelik G, Sever L, Shroff R, Vidal E, Wühl E, Gondan M, Melk A, Querfeld U, Haffner D, Schaefer F; 4C Study Consortium.
Doyon A, et al. Among authors: querfeld u.
PLoS One. 2015 Feb 6;10(2):e0113482. doi: 10.1371/journal.pone.0113482. eCollection 2015.
PLoS One. 2015.
PMID: 25659076
Free PMC article.
Clinical Trial.